| Session Title: Innovative PCR Applications for Clinical Diagnostics |
| |
08:30 | Single Cell Expression Profiling – Revealing Astrocyte Cell Subtypes by Correlation Mikael Kubista, Professor/Founder, TATAA Biocenter AB, Sweden
In my talk I will describe single cell expression correlation as means to classify cell subtypes. The technique exploits the correlation between expression levels of transcripts involved in related key biological processes within individual cells. The technique is used to reveal subtypes of astrocytes. |
09:00 | Determining miRNA Expression Levels in Degraded RNA Samples using Real-Time RT-qPCR and Microarray Technologies Sridar Chittur, Director/Adjunct Assistant Professor, Albany University, United States of America
This talk will provide insights into RT priming strategies for miRNA and contrast the qPCR results obtained using two popular technologies. |
09:30 | Solid State ChIP, a Novel Technique for Characterisation of Endometrial Cancer and Enhanced Use in Clinical Diagnostics Lewis Francis, Research Associate, Swansea University, United Kingdom
Novel solid state ChIP technology, Chromatrap™, used to characterise DNA-protein interactions in endometrial cancer, demonstrates faster throughput and more reliable protocols combined with greater enrichment fold values. This ChIP technology lends itself to high throughput analyses in clinical pathology. |
10:00 | Development of a LNA based miRNA RT-qPCR System and a Custom qPCR Tool for Design of miRNA and ncRNA Assays Peter Mouritzen, Vice President, Exiqon A/S, Denmark
Locked Nucleic Acid (LNA) qPCR has enabled sensitive and pre-amplification-free miRNA expression profiling in plasma samples from colorectal cancer patients and healthy controls. Strategies will be discussed for data normalization, quality control, and revealing of unwanted dataset bias. |
10:30 | Coffee and Networking in Exhibition Hall |
11:15 | qPCR Applications of microRNA and Other Noncoding RNAs Thomas Schmittgen, Associate Professor, Ohio State University, United States of America
By definition, noncoding RNAs are not translated to protein, therefore their quantification must be achieved at the RNA level. Various qPCR applications of noncoding RNAs will be discussed including analysis from challenging specimens such as plasma, pancreatic fluid and microdissected material. |
11:45 | Development of an Ultra-High Throughput Long Non-Coding RNA Screening System Jan Hellemans, COO, Ghent University Hospital, Belgium
We present pilot phase results for a novel high-throughput qPCR based lncRNA screening that allows for sensitive and accurate analysis of this novel class of biologically relevant nucleic acids with an unexplored potential for biomarker discovery. |
12:15 | Lunch and Networking in Exhibition Hall |
12:45 | Free Workshop Michelson Prize & Grants Information Session Learn about the $75 million challenge!
|
13:15 | Poster Viewing |
14:15 | Nucleic-Acid Based Applications in the Diagnostics of Highly Pathogenic Viruses Andreas Nitsche, Head, Robert Koch Institute, Germany
The presentation describes the various approaches that can be considered for the unambiguous identification of highly pathogenic agents by PCR based techniques. Beside design strategies, questions of identification and sample preparation are discussed. |
14:45 | Prognostic Test for Age-Related Macular Degeneration Preveen Ramamoorthy, Assistant Professor/Director, National Jewish Health, United States of America
This presentation will cover the development, validation and clinical utility of a prognostic test for age-related macular degeneration using FRET probe technology. |
15:15 | Coffee and Networking in Exhibition Hall |
16:00 | Biostatistics and qPCR, Applications in Translational Research Terry Hyslop, Associate Professor, Thomas Jefferson University, United States of America
From the selection of housekeeping genes, to the analytical and clinical validation of PCR assays, biostatistical considerations arise throughout applications of qPCR to translational research. We will discuss how we have successfully merged biostatistical efforts with those of a cancer research laboratory to design complex biomarker trials, discover new algorithmic approaches to determine patient risk, and move towards clinical application of qPCR markers in determining patient care. |
16:30 | qPCR Methods for Re-Engineering Microbial Genomes: Creating a New Genetic Code Peter Carr, Research Scientist, Massachusetts Institute of Technology, United States of America
We are re-engineering E. coli to remove all instances of one codon from its genome—producing a “plug and play” slot in the genetic code into which new amino acids can be programmed. New qPCR methods for multiplex SNP detection and allele frequency measurement have been crucial to these efforts. |
17:00 | Close of Conference |